This Blog Post was received from Dr. Abubaker Yaro, Editor-In-Chief for the scientific journal Annals of Tropical Medicine & Public Health. Here Dr Yaro announces the 1st International Conference on Drug Therapy in TB Infection, in Post 1 of a two-part Post describing the conference and the current state of Tuberculosis Drug Therapy. Here in Post 1, Dr Abubakar Yaro describes the conference and its objectives. Expect TB Drug Conference Post 2 soon.
The Africa Health Research Organization, AHRO, presents the International Conference on Drug Therapy in TB Infection
What: First International Conference on Drug Therapy in TB Infection
When: 6-7 January 2012
Where: Edinburgh Scotland
Who: Presented by AHRO, Africa Health Research Organization
WHY: The Problem
TB remains one of the most important public health issues worldwide. Globally it is estimated that 8.8 million new cases occur annually and of these 3.9 million are smear positive. Although there is an effective therapy through the DOT strategy and the majority of the global population are BCG vaccinated, the public health burden of TB is quite staggering. New and shorter-period drugs and vaccines are urgently needed as well as a forum where stakeholders can meet to exchange ideas.
This highly educative and exciting event aims to gather researchers, physicians, allied health workers and policy makers in Edinburgh, Scotland, from 6 to 7 January 2012 to share information on issues regarding TB medicine. There will be no concurrent sessions and the Conference committee are still accepting abstracts for the event. Abstracts, which should be no longer than 300 words, can be submitted to email@example.com.
• Professor Anthony Coates, St George’s University of London, UK
• Dr. Ian Laurenson, Director, Scottish Mycobacterium Reference Lab, Scotland
• Dr. Eisin McDonald, Health Protection Agency, Scotland
• Associate Professor Robert A Ollar, Berth Israel Medical Center, USA
• Emeritus Professor Peter Beverley, University of Oxford, UK
• Dr Amina Jindani, St George’s University of London, UK
• Dr. Zarir F Udwadia, Hinduja Hospital India & Author of Principles Of Respiratory Medicine
• Dr. Michel Tibayrenc, MIVEGEC Bolivia & Editor in Chief, Genetics & Evolution Elsevier
• Professor Hazel M Dockrell, LSHTM, UK
• Professor Stephen H Gillespie, University of St. Andrews, UK
• Professor Edith Sim, Oxford University, UK
• Dr Geoff Coxon, Strathclyde Institute of Pharmacy and Biomedical Sciences, UK
• Dr. Clifton Barry, National Institute of Allergy & Infectious Diseases, USA
Who Should Attend?
• Medical Officers
• Allied Health Workers
• Policy Makers
• Pharmaceutical Companies
Register Today: http://www.eventsbot.com/events/eb662245306
• Biology & Epidemiology of TB
• TB Immunology & Pathogenesis
• Current TB Chemotherapy
• Drug Resistance
• HIV/TB: A Deadly Syndemic
• Current Strategies in TB Drug Development: From Bench to Bedside
• TB Vaccine: Concept & Progress
Look for Part 2 of this two-part Blog series on the First International Conference on Drug Therapy in TB Infection soon. Part 2 will include discussions on Problems of TB screening and diagnosis and the current state of TB drug therapy.